EUVIMEDEUVIMED entdecken
Open Access

Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients

Jay L Koyner, Rachel H Mackey, Ning A Rosenthal, Leslie A Carabuena, J Patrick Kampf, Jorge Echeverri, Paul McPherson, Michael J Blackowicz, Toni Rodriguez, Aarti R Sanghani, Julien Textoris

Kidney360 · 2023-03 · 4 (3) · 316-325

DOI: 10.34067/kid.0005552022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, 2023-03. Verfasst von Jay L Koyner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Acute Kidney Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: bioMerieux, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Among hospitalized patients with stage 2/3 AKI, persistent severe acute kidney injury (PS-AKI) is associated with significantly longer length of stay (LOS) and higher costs during index hospitalization and 30 days postdischarge. Relative differences in LOS and costs for PS-AKI versus NPS-AKI were similar for intensive care (ICU) and non-ICU patients. Preventing PS-AKI among patients with stage 2/3 AKI may reduce hospital LOS and costs.

Background

Persistent severe acute kidney injury (PS-AKI) is associated with worse clinical outcomes, but there are no data on costs of PS-AKI. We compared costs and health care resource utilization for inpatients with PS-AKI versus not persistent severe AKI (NPS-AKI) overall and by ICU use.

Methods

This retrospective observational study included 126,528 adult US inpatients in the PINC AI Healthcare Database (PHD), discharged from January 1, 2017, to December 31, 2019, with KDIGO stage 2 or 3 AKI (by serum creatinine [SCr] criteria) during hospitalization, length of stay (LOS) ≥3 days, and ≥3 SCr measurements. Patients were categorized as PS-AKI (defined as stage 3 AKI lasting ≥3 days or with death within 3 days or stage 2/3 AKI (by SCr criteria) with dialysis within 3 days) or NPS-AKI. Generalized linear model regression compared LOS and costs during index hospitalization (total cohort) and 30 days postdischarge (survivors of index hospitalization), adjusted for patient, hospital, and clinical characteristics.

Results

Among 126,528 patients with stage 2/3 AKI, 30,916 developed PS-AKI. In adjusted models, compared with NPS-AKI, patients with PS-AKI had 32% longer total LOS (+3.3 days), 45% longer ICU LOS (+2.6 days), 46% higher total costs (+$13,143), 58% higher ICU costs (+$15,908), and during 30 days postdischarge 13% longer readmission LOS (+1.0 day), 22% higher readmission costs (+$4049), and 12% higher outpatient costs (+$206) ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryHumansHospitalizationCosts and Cost AnalysisPatientsDelivery of Health Care

Autor:innen und Institutionen

  • Section of Nephrology, University of Chicago, Chicago, Illinois.
  • Premier, Inc., PINC AI Applied Sciences, Charlotte, North Carolina, USA.
  • Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • Astute Medical Inc. (a bioMerieux company), San Diego, California.
  • Baxter Healthcare, Global Medical Affairs, Deerfield, Illinois.
  • bioMerieux, Inc., Global Medical Affairs, Durham, North Carolina.

Förderung

  • bioMerieux, Inc.

Zitieren

APA

Koyner, J. L., Mackey, R. H., Rosenthal, N. A., Carabuena, L. A., Kampf, J. P., Echeverri, J., McPherson, P., Blackowicz, M. J., Rodriguez, T., Sanghani, A. R., & Textoris, J. (2023). Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients. Kidney360, 4(3), 316-325. https://doi.org/10.34067/kid.0005552022

Vancouver

Koyner JL, Mackey RH, Rosenthal NA, Carabuena LA, Kampf JP, Echeverri J, et al. Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients. Kidney360. 2023;4(3):316-325. doi:10.34067/kid.0005552022

BibTeX
@article{Koyner2023,
  author = {Koyner, Jay L and Mackey, Rachel H and Rosenthal, Ning A and Carabuena, Leslie A and Kampf, J Patrick and Echeverri, Jorge and McPherson, Paul and Blackowicz, Michael J and Rodriguez, Toni and Sanghani, Aarti R and Textoris, Julien},
  title = {Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients},
  journal = {Kidney360},
  year = {2023},
  volume = {4},
  number = {3},
  pages = {316--325},
  doi = {10.34067/kid.0005552022}
}
Kostenlos starten →